ISU Abxis Co. Ltd
ISU Abxis Co., Ltd., a biopharmaceutical company, develops and markets products for the treatment of cancer and rare diseases worldwide. The company offers Abcertin, an imiglucerase for injection that is used as long-term enzyme replacement therapy in patients with a confirmed diagnosis of Type 1 Gaucher disease; Fabagal, an agalsidase beta for injection, which is used as a long term enzyme repla… Read more
ISU Abxis Co. Ltd (086890) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.088x
Based on the latest financial reports, ISU Abxis Co. Ltd (086890) has a cash flow conversion efficiency ratio of 0.088x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩10.56 Billion) by net assets (₩120.39 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ISU Abxis Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how ISU Abxis Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
ISU Abxis Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ISU Abxis Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sao Ta Foods JSC
VN:FMC
|
0.266x |
|
JUKCF
PINK:JUKCF
|
N/A |
|
Ador Welding Limited
NSE:ADORWELD
|
0.013x |
|
Anfield Energy Inc.
NASDAQ:AEC
|
-0.103x |
|
Bancorp. of Southern Indiana
PINK:BCSO
|
0.091x |
|
Hikal Limited
NSE:HIKAL
|
0.161x |
|
HYUNDAI FEED Inc
KQ:016790
|
0.015x |
|
Intai Technology
TWO:4163
|
0.054x |
Annual Cash Flow Conversion Efficiency for ISU Abxis Co. Ltd (2014–2024)
The table below shows the annual cash flow conversion efficiency of ISU Abxis Co. Ltd from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩100.86 Billion | ₩2.54 Billion | 0.025x | +172.20% |
| 2023-12-31 | ₩77.19 Billion | ₩-2.69 Billion | -0.035x | -459.13% |
| 2022-12-31 | ₩64.41 Billion | ₩-401.66 Million | -0.006x | +92.31% |
| 2021-12-31 | ₩71.95 Billion | ₩-5.84 Billion | -0.081x | +58.72% |
| 2020-12-31 | ₩43.57 Billion | ₩-8.56 Billion | -0.197x | +17.50% |
| 2019-12-31 | ₩55.18 Billion | ₩-13.15 Billion | -0.238x | -6.37% |
| 2018-12-31 | ₩59.73 Billion | ₩-13.38 Billion | -0.224x | -101.74% |
| 2017-12-31 | ₩62.05 Billion | ₩-6.89 Billion | -0.111x | -86.96% |
| 2016-12-31 | ₩45.58 Billion | ₩-2.71 Billion | -0.059x | +28.68% |
| 2015-12-31 | ₩46.59 Billion | ₩-3.88 Billion | -0.083x | +87.39% |
| 2014-12-31 | ₩17.41 Billion | ₩-11.49 Billion | -0.660x | -- |